Quality assurance in surgical oncology (QASO) within the European Organization for Research and Treatment of Cancer (EORTC): Current status and future prospects

European Journal of Cancer

Volumn 37, Issue 12, 2001, Pages 1450-1462

  Landheer, M L E A ^a   Therasse, P ^a   Van De Velde, C J H ^b  

^a EORTC DATA CENTER   (Belgium)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Clinical protocols; Clinical trials; Data collection; Physicians' role; Practice guidelines; Practice patterns; Programme evaluation; Quality control; Quality of health care; Surgery

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SURGERY; MEDICAL LITERATURE; MULTIMODALITY CANCER THERAPY; ORGANIZATION; PRIORITY JOURNAL; QUALITY CONTROL; STANDARDIZATION; SURGICAL TECHNIQUE;

CLINICAL PROTOCOLS; CLINICAL TRIALS; DATA COLLECTION; EUROPE; GROUP PROCESSES; HUMANS; LYMPH NODE EXCISION; NEOPLASMS; PROGRAM EVALUATION; QUALITY ASSURANCE, HEALTH CARE; TREATMENT OUTCOME;

EID: 0034890104     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00157-5     Document Type: Article

References (49)

1. EORTC scientific strategy meeting 25-26 March
2. Quality assurance control in the EORTC cooperative group of radiotherapy. 1. Assessment of radiotherapy staff and equipment
3. Quality assurance control in the EORTC cooperative group of radiotherapy. 2. Dosimetric intercomparison
4. Quality assurance control in the EORTC cooperative group of radiotherapy 3. Intercomparison in an anatomical phantom
5. Quality assurance in the EORTC and implications for cooperative studies with the RTOG
6. Workshop of the EORTC Radiotherapy Group on quality assurance in cooperative trials of radiotherapy: A recommendation for EORTC Cooperative Groups
7. The programme of quality assurance of the EORTC radiotherapy group. A historical overview
8. Quality audit of radiotherapy with EORTC mailed in water TL-dosimetry
9. Rationale for a quality assurance programme in clinical trials of conservative management of breast carcinoma
10. Entrance and exit TL-dosimetry in the conservative treatment of breast cancer: A pilot study for the EORTC-Radiotherapy Cooperative Group
11. Quality assurance of the EORTC trial 22881/10882: 'Assessment of the role of the booster dose in breast conserving therapy': The dummy run
12. Quality assurance in conservative treatment of early breast cancer: Report on a consensus meeting of the EORTC radiotherapy and breast cancer cooperative groups and the EUSOMA (European Society of Mastology)
13. Mailed, TL dosimetry programme for machine output check and clinical application in the EORTC radiotherapy group
14. EORTC radiotherapy group quality assurance: Mechanical checks and beam alignments of megavoltage equipment
15. EORTC guidelines for writing protocols for clinical trials of radiotherapy
16. Quality assurance of the EORTC radiotherapy trial 22863 for prostatic cancer: The dummy run
17. Profile of radiotherapy departments contributing to the cooperative group of radiotherapy of the EORTC
18. Quality assurance of the EORTC Trial 22881/10882: Boost versus no boost in breast conserving therapy. An overview
19. Quality assurance of the EORTC radiotherapy trial 22931 for head and neck carcinomas: The dummy run
20. Clinical impact of dosimetry quality assurance programmes assessed by radiobiological modelling of data from the thermoluminescent dosimetry study of the European Organization for Research and Treatment of Cancer
21. Quality control of validity of data collected in clinical trials
22. EORTC joint ventures in quality control: Treatment-related variables and data acquisition in chemotherapy trials
23. Chemotherapy administration and data collection in an EORTC collaborative group - Can we trust the results?
24. Quality control in multicentric clinical trials. An experience of the EORTC Gynecological Cancer Cooperative Group
25. The use of a systemic therapy checklist improves the quality of data acquisition and recording in multicentre trials. A study of the EORTC soft tissue and bone sarcoma group
26. Surgical quality control in an international randomised clinical trial
27. Recurrence and survival after total mesorectal excision for rectal cancer
28. Total mesorectal excision in the operative treatment of carcinoma of the rectum
29. Rectal cancer: The Basingstoke experience of total mesorectal excision, 1978-1997
30. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: An international analysis of 1411 patients
31. Effect of a surgical training programme on outcome of rectal cancer in the county of Stockholm
32. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy
33. More detailed documentation of operative procedures in breast conserving treatment: What good will it do us?
34. Quality assurance of surgery in clinical trials
35. Documentation of the surgical procedure: A tool for quality assessment for breast conservative treatment
36. Comparison of the surgical procedures for breast conserving treatment of early breast cancer in seven EORTC centres
37. Long-term results of a randomised trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial
38. The effect of local recurrence on survival in resected osteosarcoma
39. Prognostic factors in resectable gastric cancer: Results of EORTC study no. 40813 on FAM adjuvant chemotherapy
40. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer
41. Treatment of superficial bladder tumours: Achievements and needs
42. The sentinel node in breast cancer - A multicenter validation study
43. Pathology data in the central databases of multicenter randomised trials need to be based on pathology reports and controlled by trained quality managers